Apr 26, 2017 | Compliance, Legal, and Malpractice, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing
McKesson agreed to pay a $150 million settlement for not reporting suspicious opioid orders and this case establishes a precedent that could ensnare other providers
In today’s world of the Internet-of-Things, it is becoming easier to collect data on every purchase made by individuals and companies. That ability to track the actions of consumers and commercial business has not escaped the notice of law enforcement and regulatory authorities. For example, at some future point, it could be that regulators would want to access data held by clinical laboratories on the test ordering patterns of their client physicians.
A recent ruling by the US Department of Justice (DOJ) in a case involving McKesson Corp. (NYSE:MCK), may set a precedent that could eventually be cause for concern for medical laboratories that work with physicians who may be ordering more tests than are considered medically necessary under current regulations.
McKesson is a retail distributor of pharmaceuticals, and provider of health information and care management technologies and medical supplies. In a settlement with the DOJ, McKesson agreed to pay a record $150 million in civil penalties, as well as a staggered suspension of sales of controlled substances for a period of time from distribution centers in Colorado, Ohio, Florida, and Michigan, for alleged violations of the Controlled Substances Act (CSA). (more…)
Apr 24, 2017 | Compliance, Legal, and Malpractice, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing, Management & Operations
Pathologists and clinical laboratory managers need to understand the reasons why different consumers have entirely different financial experiences with the health insurance obtained under the ACA
One of the interesting consequences of the Affordable Care Act is that there are different classes of consumers who have completely different experiences with the health insurance coverage obtained through the ACA’s health insurance exchanges. It is important for pathologists as well as clinical laboratory managers to understand this fascinating outcome from the Affordable Care Act.
On one end of the spectrum are consumers who—because their income is at or just above the poverty line—get ACA health insurance coverage with full or nearly all of the premium subsidized be the federal government. They are the happiest with the law. That is, until they need to pay deductibles of as much as $5,000 per year for individuals and $10,000 per year for a family.
At the other end of the spectrum are the consumers with incomes at or above the 400% of the poverty level. Because these individuals get little or no federal premium subsidy, they are stuck paying the full price of their health insurance coverage. It is this group that is most unhappy with the ACA. And, not only are they paying hefty monthly premiums for coverage, they are also stuck with the $5,000 and $10,000 annual deductible requirements. (more…)
Apr 19, 2017 | Laboratory Hiring & Human Resources, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing, Management & Operations
Pathologists and clinical laboratories should be watching for the arrival of community paramedicine programs in their communities
Studies reveal that a sizeable proportion of 911 medical emergency calls result in an ambulance ride and emergency room visit for a medical condition that is relatively simple and not truly urgent. Recognizing this fact, some innovative health systems are creating a mobile “emergency room” service that can go to the patient’s home, provide appropriate care, and save the time and costs of the ambulance transport and emergency room (ER) visit.
This care model is being called “community paramedicine.” Pathologists and clinical laboratory managers should see this as a new example of how the traditional provision of healthcare services is being rethought. The goal is to combine modern workflow redesign techniques with new information technologies (IT) and medical laboratory tests to improve patient care while eliminating unnecessary cost.
The concept of bringing the ER to the patient’s home is consistent with the US medical industry’s shift toward offsite healthcare, which can include telehealth, to accommodate the growing population of geriatric, house-bound, and remote location patients. That is why programs are being created that allow patients to receive ER care in the comfort of their own homes. (more…)
Apr 7, 2017 | Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing, Management & Operations
Medical laboratories now taking the steps to deliver patient-centric lab testing services report solid successes in improving patient/physician satisfaction, increasing lab revenue, and gaining more network access
Evidence is accumulating that “patient-centric” medical laboratory testing services are poised to become one of the most important new paradigms to reshape the house of pathology and clinical laboratory medicine in decades. Better yet, patient-centric lab services will earn more revenue for those labs that move fastest to incorporate these capabilities into their service mix.
“The paradigm of patient-center lab testing services couldn’t come at a better time for the clinical laboratory industry. Most labs are reeling from what is now nearly a full decade of successive and painful reductions in lab test prices and lab budgets,” observed Robert Michel, Editor-in-Chief of The Dark Report, which is Dark Daily’s sister publication. “After years of aggressive cost-cutting, most labs are down to the bare essentials and staff is overworked. That is why there is an urgent need for an operational and clinical strategy that will earn more payment from payers. (more…)
Apr 5, 2017 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing
As cognitive and cloud computing continue to advance, and mobile technologies become more accessible across the globe, innovative apps and mobile attachments are using algorithms to replace the need for complex and time-consuming diagnostic tests
Mobile healthcare—also known as mHealth—is attracting plenty of research dollars as entrepreneurs look for ways improve consumers’ access to various medical services in ways that could reduce healthcare costs. For that reason, some mHealth solutions may be used by clinical laboratories and pathology groups to give patients faster access to diagnostic services and information about medical laboratory tests.
Most mHealth solutions excel at doing a single, defined task well. In some cases, they are faster and as accurate as human-based testing or observation. However, few solutions can tackle complex diagnostics, such as determining the pathogens involved in sepsis. And mHealth cannot replace the human element of communication and empathy, which will always have a place in the medical process. (more…)
Apr 3, 2017 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing, Management & Operations
Report states IVD companies are focusing on core lab, seeking China FDA approval, and targeting urgent care
Several of the same powerful trends reshaping healthcare and clinical laboratory services are having equally significant influence on in vitro diagnostics (IVD) manufacturers. In particular, the consolidation of hospitals and physicians, as well as the emergence of new sites of service—such as urgent care centers and retail clinics—are motivating IVD companies to tailor new diagnostic systems to the unique needs of these entities.
Kalorama, a division of MarketResearch.com, has released its list of Top-Trends that will affect IVD developers in 2017. IVDs are at the heart of the medical laboratory industry. Thus, these reports are critical to keeping clinical laboratory managers and pathology groups informed on anything that could affect the production, voracity, and availability of diagnostic testing. (more…)
